The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer.
about
Uptake of Radium-223 Dichloride and Early [(18)F]NaF PET Response Are Driven by Baseline [(18)F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients.Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy.On the 18F-fluoride PET imaging quantification to predict 223Ra-dichloride treatment response.Dosimetry-Based Consideration on Remission and Relapse after Therapy with 223Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case Report.
P2860
The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The potential of 223Ra and 18F ...... ion-resistant prostate cancer.
@en
The potential of 223Ra and 18F ...... ion-resistant prostate cancer.
@nl
type
label
The potential of 223Ra and 18F ...... ion-resistant prostate cancer.
@en
The potential of 223Ra and 18F ...... ion-resistant prostate cancer.
@nl
prefLabel
The potential of 223Ra and 18F ...... ion-resistant prostate cancer.
@en
The potential of 223Ra and 18F ...... ion-resistant prostate cancer.
@nl
P2093
P2860
P50
P1476
The potential of 223Ra and 18F ...... ion-resistant prostate cancer.
@en
P2093
Cecilia Hindorf
Christopher C Parker
Sarah J Chittenden
P2860
P2888
P304
P356
10.1007/S00259-017-3744-Y
P577
2017-06-13T00:00:00Z